EUVIMEDEUVIMED entdecken
Crossref

Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives

Muhammad Umar Farooq, Charles H. Lawrie, Nan-Nan Deng

Chemical Engineering Journal · 2024-04 · 486 · 150356

DOI: 10.1016/j.cej.2024.150356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2024-04. Verfasst von Muhammad Umar Farooq und 2 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 348 Literaturangaben. Gefördert von: Shanghai Municipal Natural Science Foundation, National Natural Science Foundation of China, Shanghai Jiao Tong University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Shanghai Municipal Natural Science Foundation
  • National Natural Science Foundation of China
  • Shanghai Jiao Tong University

Zitieren

APA

Farooq, M. U., Lawrie, C. H., & Deng, N. (2024). Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives. Chemical Engineering Journal, 486, 150356. https://doi.org/10.1016/j.cej.2024.150356

Vancouver

Farooq MU, Lawrie CH, Deng N. Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives. Chemical Engineering Journal. 2024;486:150356. doi:10.1016/j.cej.2024.150356

BibTeX
@article{Farooq2024,
  author = {Farooq, Muhammad Umar and Lawrie, Charles H. and Deng, Nan-Nan},
  title = {Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives},
  journal = {Chemical Engineering Journal},
  year = {2024},
  volume = {486},
  pages = {150356},
  doi = {10.1016/j.cej.2024.150356}
}
Kostenlos starten →